CG Oncology CGON EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from CG Oncology’s reported figures.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's EBIT?
- CG Oncology (CGON) reported EBIT of -$66.39M in Q1 2026.
- How has CG Oncology's EBIT changed year-over-year?
- CG Oncology's EBIT decreased by 57.3% year-over-year, from -$42.2M to -$66.39M.
- What is the long-term trend for CG Oncology's EBIT?
- Over 2 years (2023 to 2025), CG Oncology's EBIT has grown at a 85.5% compound annual growth rate (CAGR), from -$55.45M to -$190.77M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.